The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 06, 2021

Filed:

Mar. 17, 2017
Applicant:

Syntarga Bv, Nijmegen, NL;

Assignee:

SYNTARGA BV, Nijmegen, NL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/44 (2006.01); A61K 47/64 (2017.01); A61K 31/437 (2006.01); C07D 471/04 (2006.01); A61K 47/65 (2017.01); A61K 47/60 (2017.01); A61K 47/54 (2017.01); A61K 38/38 (2006.01); A61K 47/68 (2017.01);
U.S. Cl.
CPC ...
A61K 47/64 (2017.08); A61K 31/437 (2013.01); A61K 38/385 (2013.01); A61K 39/44 (2013.01); A61K 47/545 (2017.08); A61K 47/60 (2017.08); A61K 47/643 (2017.08); A61K 47/646 (2017.08); A61K 47/65 (2017.08); A61K 47/6803 (2017.08); A61K 47/6851 (2017.08); C07D 471/04 (2013.01);
Abstract

This invention relates to novel analogs of the DNA-alkylating agent CC-1065 and to their conjugates. Furthermore this invention concerns intermediates for the preparation of said agents and conjugates. The conjugates are designed to release their (multiple) payload after one or more activation steps and/or at a rate and time span controlled by the conjugate in order to selectively deliver and/or controllably release one or more of said DNA alkylating agents. The agents, conjugates, and intermediates can be used to treat an illness that is characterized by undesired (cell) proliferation. As an example, the agents and the conjugates of this invention may be used to treat a tumor.


Find Patent Forward Citations

Loading…